Company: RGNT
Filing Date: 2025-01-24
Form Type: DRS
Source: 0001213900-25-006245
Chunk: 11

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-01-24
Form: DRS
Chunk 11
---
ants not-to-compete under current Israeli law that might result in added competition for our products.                               |
| ● | Provisions of Israeli law                                                                                                                 
 and our amended and restated articles of association to be in effect upon the completion of this offering may delay, prevent or otherwise 
 impede a merger with, or an acquisition of, us, which could prevent a change of control, even when the terms of such a transaction        
 are favorable to us and our shareholders.                                                                                                 |

| ● | It may be difficult to                                                                                                                         
 enforce a judgment of a U.S. court against us and our executive officers and directors and the Israeli experts named in this prospectus        
 in Israel or the United States, to assert U.S. securities laws claims in Israel or to serve process on our executive officers and              
 directors and these experts.                                                                                                                   |
| ● | Your rights and responsibilities                                                                                                               
 as a shareholder will be governed in key respects by Israeli law, which differs in some material respects from the rights and responsibilities 
 of shareholders of U.S. companies.                                                                                                             |

<div align='center'>8</div>

Corporate Information We are an Israeli corporation based in Israel and incorporated in 2004. Our address is 60 Medinat Hayehudim, Herzliya 4676652, Israel. Our telephone number is +972.9.960.1917. Our website address is www.regentis.co.il. The information contained on our website and available through our website is not incorporated by reference into and should not be considered a part of this prospectus, and the reference to our website in this prospectus is an inactive textual reference only. Implications of Being an “Emerging Growth Company” and a “Foreign Private Issuer” Emerging Growth Company As a company with less than $1.235 billion in revenue during our last fiscal year, we qualify as an “emerging growth company” as defined in the JOBS Act. An emerging growth company may take advantage of specified reduced reporting and other burdens that are otherwise applicable generally to public companies. In particular, as an emerging growth company, we:

| ● | may present only two years                                                                                                    
 of audited financial statements and only two years of related Management’s Discussion and Analysis of Financial Condition and 
 Results of Operations disclosure in our initial registration statement;                                                       |

| ● | are not required to provide                                                                                                      
 a detailed narrative disclosure discussing our compensation principles, objectives and elements and analyzing how those elements 
 fit with our principles and objectives, which is